Please use this identifier to cite or link to this item: http://hdl.handle.net/1783.1/6920

Plasma or serum marker and process for detection of cancer

Authors Hsiao, Wen Luan Wendy HKUST affiliated (currently or previously).
Wong, Sze Chuen Cesar HKUST affiliated (currently or previously).
Issue Date 2010-10-12
Source US Patent , 7,811,752 B2, 2010
Summary This disclosures provides, in one aspect, a method for detecting non-clinically diagnosed cancer in a patient. In one embodiment, the method includes extracting blood serum or plasma from the patient, and then detecting beta-catenin RNA in the blood serum or plasma. In addition, in this embodiment, the method includes determining the presence of the cancer based on the detected beta-catenin RNA. In another aspect, this disclosure provides another embodiment of a method for detecting non-clinically diagnosed cancer in a patient. In this embodiment, the method includes extracting blood serum or plasma from the patient, and then detecting beta-catenin DNA in the blood serum or plasma. In addition, in this embodiment, the method includes determining the presence of the cancer based on the detected beta-catenin DNA. Related methods for detecting non-clinically diagnosed cancer in a patient comprising detecting beta-catenin-associated gene RNA, and beta-catenin-associated gene DNA, in the blood serum or plasma are also disclosed.
Subjects
Language English
Format Patent
Access
Files in this item:
File Description Size Format
US7811752.pdf 1597691 B Adobe PDF